In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
D000911:Antibodies, Monoclonal; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003165:Complement System Proteins; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D009447:Neuroblastoma / Q000503:physiopathology / Q000628:therapy*; D013997:Time Factors; D014182:Transplantation, Autologous / Q000009:adverse effects / Q000379:methods*
D000911:Antibodies, Monoclonal; D003165:Complement System Proteins